$MO
ALTRIA GROUP, INC.

2020 Q4 Form 10-Q Financial Statement

#000076418020000106 Filed on October 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $6.304B $7.123B $6.856B
YoY Change 4.94% 3.89% 0.28%
Cost Of Revenue $3.142B $1.961B $1.915B
YoY Change 7.6% 2.4% -5.99%
Gross Profit $3.146B $3.717B $3.497B
YoY Change 2.01% 6.29% 7.43%
Gross Profit Margin 49.9% 52.18% 51.01%
Selling, General & Admin $217.0M $522.0M $546.0M
YoY Change -60.04% -4.4% -19.71%
% of Gross Profit 6.9% 14.04% 15.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $65.00M $62.00M $57.00M
YoY Change 3.17% 8.77% -10.94%
% of Gross Profit 2.07% 1.67% 1.63%
Operating Expenses $217.0M $522.0M $546.0M
YoY Change -60.04% -4.4% -19.71%
Operating Profit $2.929B $3.160B $2.944B
YoY Change 15.27% 7.34% 15.13%
Interest Expense -$120.0M -$782.0M $46.00M
YoY Change -121.47% -1800.0% 53.33%
% of Operating Profit -4.1% -24.75% 1.56%
Other Income/Expense, Net $19.00M $3.000M $24.00M
YoY Change 35.71% -87.5% 14.29%
Pretax Income $2.541B -$324.0M -$2.128B
YoY Change -307.77% -84.77% -181.6%
Income Tax $596.0M $632.0M $474.0M
% Of Pretax Income 23.46%
Net Earnings $1.924B -$952.0M -$2.600B
YoY Change -206.36% -63.38% -233.81%
Net Earnings / Revenue 30.52% -13.37% -37.92%
Basic Earnings Per Share -$0.51 -$1.39
Diluted Earnings Per Share $1.035M -$0.51 -$1.39
COMMON SHARES
Basic Shares Outstanding 1.858B shares 1.858B shares 1.868B shares
Diluted Shares Outstanding 1.859B shares 1.868B shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.945B $4.123B $1.604B
YoY Change 133.59% 157.04% -32.97%
Cash & Equivalents $4.945B $4.123B $1.604B
Short-Term Investments
Other Short-Term Assets $69.00M $263.0M $319.0M
YoY Change -73.66% -17.55% -24.76%
Inventory $1.966B $1.862B $2.188B
Prepaid Expenses
Receivables $137.0M $151.0M $165.0M
Other Receivables $0.00 $0.00 $15.00M
Total Short-Term Assets $7.117B $6.399B $4.291B
YoY Change 47.53% 49.13% -16.92%
LONG-TERM ASSETS
Property, Plant & Equipment $2.012B $2.009B $1.962B
YoY Change 0.65% 2.4% 3.75%
Goodwill $5.177B $5.177B $5.262B
YoY Change 0.0% -1.62% -0.85%
Intangibles $12.62B $12.63B $12.69B
YoY Change -0.57% -0.43% 2.45%
Long-Term Investments $19.53B $19.41B $26.93B
YoY Change -16.11% -27.93% 51.07%
Other Assets $964.0M $1.025B $1.364B
YoY Change -3.89% -24.85% 156.39%
Total Long-Term Assets $40.30B $40.25B $48.62B
YoY Change -9.34% -17.21% 25.35%
TOTAL ASSETS
Total Short-Term Assets $7.117B $6.399B $4.291B
Total Long-Term Assets $40.30B $40.25B $48.62B
Total Assets $47.41B $46.65B $52.91B
YoY Change -3.77% -11.83% 20.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $380.0M $348.0M $246.0M
YoY Change 16.92% 41.46% -14.88%
Accrued Expenses $5.280B $4.590B $4.614B
YoY Change 7.27% -0.52% -4.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.500B $1.500B $1.000B
YoY Change 50.0% 50.0% -50.17%
Total Short-Term Liabilities $9.063B $8.290B $7.662B
YoY Change 10.88% 8.2% -11.38%
LONG-TERM LIABILITIES
Long-Term Debt $27.97B $27.76B $26.90B
YoY Change 3.44% 3.17% 126.15%
Other Long-Term Liabilities $381.0M $409.0M $316.0M
YoY Change 10.43% 29.43% 52.66%
Total Long-Term Liabilities $28.35B $28.16B $27.22B
YoY Change 3.52% 3.47% 124.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.063B $8.290B $7.662B
Total Long-Term Liabilities $28.35B $28.16B $27.22B
Total Liabilities $44.45B $43.38B $42.24B
YoY Change 3.58% 2.71% 48.62%
SHAREHOLDERS EQUITY
Retained Earnings $34.68B $34.36B $39.91B
YoY Change -5.09% -13.92% -8.89%
Common Stock $6.845B $6.908B $6.895B
YoY Change -0.87% 0.19% 0.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $34.34B $34.34B $33.86B
YoY Change -0.04% 1.44% 2.07%
Treasury Stock Shares 947.5M shares 937.8M shares
Shareholders Equity $2.839B $3.139B $10.55B
YoY Change
Total Liabilities & Shareholders Equity $47.41B $46.65B $52.91B
YoY Change -3.77% -11.83% 20.39%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $1.924B -$952.0M -$2.600B
YoY Change -206.36% -63.38% -233.81%
Depreciation, Depletion And Amortization $65.00M $62.00M $57.00M
YoY Change 3.17% 8.77% -10.94%
Cash From Operating Activities $2.541B $898.0M $2.882B
YoY Change -0.86% -68.84% 6.11%
INVESTING ACTIVITIES
Capital Expenditures -$69.00M -$56.00M -$81.00M
YoY Change -19.77% -30.86% 35.0%
Acquisitions
YoY Change
Other Investing Activities $33.00M $12.00M -$355.0M
YoY Change -67.0% -103.38% -8975.0%
Cash From Investing Activities -$36.00M -$44.00M -$436.0M
YoY Change -357.14% -89.91% 678.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.683B -1.564B -2.637B
YoY Change -18.38% -40.69% 55.94%
NET CHANGE
Cash From Operating Activities 2.541B 898.0M 2.882B
Cash From Investing Activities -36.00M -44.00M -436.0M
Cash From Financing Activities -1.683B -1.564B -2.637B
Net Change In Cash 822.0M -710.0M -191.0M
YoY Change 59.61% 271.73% -119.71%
FREE CASH FLOW
Cash From Operating Activities $2.541B $898.0M $2.882B
Capital Expenditures -$69.00M -$56.00M -$81.00M
Free Cash Flow $2.610B $954.0M $2.963B
YoY Change -1.47% -67.8% 6.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000764180
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.3333
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.3333
CY2019Q4 mo Allowance For Sales Discounts Goods
AllowanceForSalesDiscountsGoods
0 USD
CY2020Q3 mo Allowance For Sales Discounts Goods
AllowanceForSalesDiscountsGoods
0 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-08940
dei Entity Registrant Name
EntityRegistrantName
Altria Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3260245
dei Entity Address Address Line1
EntityAddressAddressLine1
6601 West Broad Street,
dei Entity Address City Or Town
EntityAddressCityOrTown
Richmond,
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23230
dei City Area Code
CityAreaCode
804
dei Local Phone Number
LocalPhoneNumber
274-2200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1858419165 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4123000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2117000000 USD
CY2020Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
151000000 USD
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
152000000 USD
CY2020Q3 mo Inventory Raw Materials Plant Material Netof Reserves
InventoryRawMaterialsPlantMaterialNetofReserves
754000000 USD
CY2019Q4 mo Inventory Raw Materials Plant Material Netof Reserves
InventoryRawMaterialsPlantMaterialNetofReserves
874000000 USD
CY2020Q3 mo Other Inventory Raw Materials Netof Reserves
OtherInventoryRawMaterialsNetofReserves
206000000 USD
CY2019Q4 mo Other Inventory Raw Materials Netof Reserves
OtherInventoryRawMaterialsNetofReserves
192000000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
450000000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
696000000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
452000000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
531000000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
1862000000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
2293000000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
263000000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
262000000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
6399000000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
4824000000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5173000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5074000000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3164000000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3075000000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2009000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1999000000 USD
CY2020Q3 mo Accrued Settlement Liability Current
AccruedSettlementLiabilityCurrent
3206000000 USD
CY2019Q4 mo Accrued Settlement Liability Current
AccruedSettlementLiabilityCurrent
3346000000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1113000000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1545000000 USD
CY2020Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
1602000000 USD
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1565000000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8290000000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8174000000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
27755000000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
27042000000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4724000000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5083000000 USD
CY2020Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
404000000 USD
CY2019Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
473000000 USD
CY2020Q3 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
1798000000 USD
CY2019Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
1797000000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3781000000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2864000000 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
409000000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
345000000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
43380000000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
42914000000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
39000000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
38000000 USD
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2805961317 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2805961317 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
935000000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
935000000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5973000000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5970000000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34356000000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
36539000000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
348000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6222000000 USD
CY2020Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
947542152 shares
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
947979763 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
34344000000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
34358000000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
3139000000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
93000000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
5177000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
5177000000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12633000000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12687000000 USD
CY2020Q3 mo Equity Security Investments
EquitySecurityInvestments
19408000000 USD
CY2019Q4 mo Equity Security Investments
EquitySecurityInvestments
23581000000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1025000000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1003000000 USD
CY2020Q3 us-gaap Assets
Assets
46651000000 USD
CY2019Q4 us-gaap Assets
Assets
49271000000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1500000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1000000000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
325000000 USD
CY2020Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
521000000 USD
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
393000000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
97000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3232000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6319000000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46651000000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49271000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19849000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19103000000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7123000000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6856000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5909000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5367000000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1961000000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1915000000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
4063000000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
4109000000 USD
CY2020Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1445000000 USD
CY2019Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1444000000 USD
us-gaap Gross Profit
GrossProfit
9877000000 USD
us-gaap Gross Profit
GrossProfit
9627000000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
3717000000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
3497000000 USD
mo Marketing Administrationand Research Costs
MarketingAdministrationandResearchCosts
1585000000 USD
mo Marketing Administrationand Research Costs
MarketingAdministrationandResearchCosts
1654000000 USD
CY2020Q3 mo Marketing Administrationand Research Costs
MarketingAdministrationandResearchCosts
557000000 USD
CY2019Q3 mo Marketing Administrationand Research Costs
MarketingAdministrationandResearchCosts
552000000 USD
mo Asset Impairmentand Business Exit Costs Excluding Net Pension Cost Credit
AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
0 USD
mo Asset Impairmentand Business Exit Costs Excluding Net Pension Cost Credit
AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
74000000 USD
CY2020Q3 mo Asset Impairmentand Business Exit Costs Excluding Net Pension Cost Credit
AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
0 USD
CY2019Q3 mo Asset Impairmentand Business Exit Costs Excluding Net Pension Cost Credit
AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
1000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8292000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
7899000000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3160000000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2944000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-893000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-989000000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-310000000 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-293000000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-58000000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-40000000 USD
CY2020Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-3000000 USD
CY2019Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-24000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-306000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
866000000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-472000000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
333000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
2600000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
4500000000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
2600000000 USD
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
4500000000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-202000000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1327000000 USD
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-105000000 USD
CY2019Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-636000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4349000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1989000000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-324000000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2128000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1817000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1473000000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
632000000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
474000000 USD
us-gaap Profit Loss
ProfitLoss
2532000000 USD
us-gaap Profit Loss
ProfitLoss
516000000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-956000000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-2602000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4000000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
us-gaap Net Income Loss
NetIncomeLoss
2543000000 USD
us-gaap Net Income Loss
NetIncomeLoss
516000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-952000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2600000000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.39
us-gaap Profit Loss
ProfitLoss
2532000000 USD
us-gaap Profit Loss
ProfitLoss
516000000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-956000000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-2602000000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-27000000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-84000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
15000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-26000000 USD
us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-928000000 USD
us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
53000000 USD
CY2020Q3 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-15000000 USD
CY2019Q3 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
221000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
23000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-917000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
145000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
244000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1615000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
661000000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-963000000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2358000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-11000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4000000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1626000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
661000000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-959000000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2356000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6319000000 USD
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
2530000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-917000000 USD
mo Adjustmentsto Additional Paidin Capital Sharebased Compensation Requisite Service Period Recognitionand Income Tax Effect Net
AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
17000000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.54
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4726000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-9000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3232000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14789000000 USD
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
513000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
145000000 USD
mo Adjustmentsto Additional Paidin Capital Sharebased Compensation Requisite Service Period Recognitionand Income Tax Effect Net
AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
11000000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.44
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4568000000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
346000000 USD
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
88000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-5000000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10637000000 USD
CY2019Q3 mo Adjustmentsto Additional Paidin Capital Sharebased Compensation Requisite Service Period Recognitionand Income Tax Effect Net
AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
8000000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
2000000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
3000000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5786000000 USD
CY2020Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-957000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000000 USD
CY2020Q3 mo Adjustmentsto Additional Paidin Capital Sharebased Compensation Requisite Service Period Recognitionand Income Tax Effect Net
AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
10000000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.86
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3232000000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14466000000 USD
CY2019Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-2603000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
244000000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.84
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1571000000 USD
CY2019Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
88000000 USD
CY2019Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-5000000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10637000000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1000000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1000000 USD
us-gaap Profit Loss
ProfitLoss
2532000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
866000000 USD
us-gaap Restructuring Costs
RestructuringCosts
-33000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1000000 USD
us-gaap Profit Loss
ProfitLoss
516000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
192000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
163000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-111000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-261000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-306000000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
108000000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
221000000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-202000000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1327000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
2600000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
4500000000 USD
us-gaap Restructuring Costs
RestructuringCosts
-42000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
21000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-136000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-147000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-157000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
174000000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
504000000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
359000000 USD
mo Increase Decrease In Settlement Payable
IncreaseDecreaseInSettlementPayable
-140000000 USD
mo Increase Decrease In Settlement Payable
IncreaseDecreaseInSettlementPayable
-360000000 USD
us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
16000000 USD
us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
51000000 USD
us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
-35000000 USD
us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
-42000000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
591000000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
376000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5844000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5274000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
162000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
160000000 USD
mo Payments To Acquire Equity Method Investments And Derivative Instruments Investing Activities
PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities
0 USD
mo Payments To Acquire Equity Method Investments And Derivative Instruments Investing Activities
PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities
1863000000 USD
mo Payments To Acquire Businesses And Assets
PaymentsToAcquireBusinessesAndAssets
0 USD
mo Payments To Acquire Businesses And Assets
PaymentsToAcquireBusinessesAndAssets
421000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-55000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-32000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-107000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2412000000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3000000000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3000000000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
12800000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1993000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
16265000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1144000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
346000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4690000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4498000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-16000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-127000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3713000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2650000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2024000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
212000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2160000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1433000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4184000000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1645000000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4123000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2117000000 USD
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1000000 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
60000000 USD
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
43000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4184000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2160000000 USD
CY2020Q3 mo Common Stock Dividend Rate Percentage Increase
CommonStockDividendRatePercentageIncrease
0.024
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.86
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.84
CY2020Q3 mo Common Stock Dividend Rate Annual Per Share
CommonStockDividendRateAnnualPerShare
3.44
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
250000000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
362000000 USD
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
three days
CY2020Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
151000000 USD
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
152000000 USD
mo Other Restructuring Costs Including Net Pension Cost Credit
OtherRestructuringCostsIncludingNetPensionCostCredit
395000000 USD
mo Restructuring Charges Including Net Pension Cost Credit
RestructuringChargesIncludingNetPensionCostCredit
395000000 USD
mo Asset Impairmentand Business Exit Costs Excluding Net Pension Cost Credit
AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
74000000 USD
mo Other Restructuring Costs Including Net Pension Cost Credit
OtherRestructuringCostsIncludingNetPensionCostCredit
25000000 USD
mo Restructuring Charges Including Net Pension Cost Credit
RestructuringChargesIncludingNetPensionCostCredit
99000000 USD
mo Net Periodic Defined Benefits Expense Reversalof Expense Excluding Service Cost Component Implementation Costs
NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts
0 USD
mo Net Periodic Defined Benefits Expense Reversalof Expense Excluding Service Cost Component Restructuring Charges
NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges
0 USD
mo Net Periodic Defined Benefits Income Reversalof Income Excluding Service Cost Component Asset Impairment And Business Exit Costs
NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts
12000000 USD
mo Net Periodic Defined Benefits Expense Reversalof Expense Excluding Service Cost Component Implementation Costs
NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts
0 USD
mo Net Periodic Defined Benefits Expense Reversalof Expense Excluding Service Cost Component Restructuring Charges
NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges
12000000 USD
CY2020Q3 us-gaap Investments
Investments
19408000000 USD
CY2019Q4 us-gaap Investments
Investments
23581000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-306000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
866000000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-472000000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
333000000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-202000000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1296000000 USD
CY2020Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-105000000 USD
CY2019Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-636000000 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
395000000 USD
us-gaap Restructuring Charges
RestructuringCharges
395000000 USD
mo Asset Impairmentand Business Exit Costs
AssetImpairmentandBusinessExitCosts
86000000 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
25000000 USD
us-gaap Restructuring Charges
RestructuringCharges
111000000 USD
CY2020Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
1000000 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
1000000 USD
CY2019Q3 mo Asset Impairmentand Business Exit Costs
AssetImpairmentandBusinessExitCosts
1000000 USD
CY2019Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
4000000 USD
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
5000000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
67000000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
42000000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
25000000 USD
us-gaap Net Income Loss
NetIncomeLoss
2543000000 USD
us-gaap Net Income Loss
NetIncomeLoss
516000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-952000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2600000000 USD
mo Participating Securities Distributedand Undistributed Earnings Loss Basicand Diluted
ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
6000000 USD
mo Participating Securities Distributedand Undistributed Earnings Loss Basicand Diluted
ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
5000000 USD
CY2020Q3 mo Participating Securities Distributedand Undistributed Earnings Loss Basicand Diluted
ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
1000000 USD
CY2019Q3 mo Participating Securities Distributedand Undistributed Earnings Loss Basicand Diluted
ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
1000000 USD
mo Net Income Loss Availableto Common Stockholders Basicand Diluted
NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted
2537000000 USD
mo Net Income Loss Availableto Common Stockholders Basicand Diluted
NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted
511000000 USD
CY2020Q3 mo Net Income Loss Availableto Common Stockholders Basicand Diluted
NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted
-953000000 USD
CY2019Q3 mo Net Income Loss Availableto Common Stockholders Basicand Diluted
NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted
-2601000000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1858000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1871000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1858000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1868000000 shares
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
1000000 shares
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
0 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
1000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1859000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1871000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1859000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1868000000 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19849000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19103000000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7123000000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6856000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8292000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
7899000000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3160000000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2944000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-893000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-989000000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-310000000 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-293000000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-58000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-306000000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-40000000 USD
CY2020Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-3000000 USD
CY2019Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-24000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
866000000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-472000000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
333000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
2600000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
4500000000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
2600000000 USD
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
4500000000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-202000000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1327000000 USD
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-105000000 USD
CY2019Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-636000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4349000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1989000000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-324000000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2128000000 USD
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
mo Debt Instrument Covenant Consolidated Ebitd Ato Interest Expense Ratio Minimum
DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum
4.0
mo Debt Instrument Consolidated Ebitd Ato Interest Expense Ratio
DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio
9.2
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
29300000000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
28000000000.0 USD
CY2020Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
244000000 USD
CY2019Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
470000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.418
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.951
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.741
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.223
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2324000000 USD
mo Valuation Allowance Deferred Tax Asset Increase In Amount
ValuationAllowanceDeferredTaxAssetIncreaseInAmount
673000000 USD
mo Valuation Allowance Deferred Tax Asset Decrease In Amount
ValuationAllowanceDeferredTaxAssetDecreaseInAmount
145000000 USD
mo Valuation Allowance Foreign Currency Translation Adjustment
ValuationAllowanceForeignCurrencyTranslationAdjustment
4000000 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2856000000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
74000000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
41000000 USD
CY2020Q3 mo Unrecognized Tax Benefitsthat Would Impact Deferred Tax Rate
UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate
33000000 USD
CY2020Q3 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
8000000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
64000000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
40000000 USD
CY2019Q4 mo Unrecognized Tax Benefitsthat Would Impact Deferred Tax Rate
UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate
24000000 USD
CY2020Q3 mo Loss Contingency Numberof States That Cap Bondor Require No Bond
LossContingencyNumberofStatesThatCapBondorRequireNoBond
47 state
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
14000000 USD
CY2018Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
112000000 USD
CY2020Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
22000000 USD
CY2019Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
13000000 USD
us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
81000000 USD
us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
151000000 USD
CY2020Q3 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
47000000 USD
CY2019Q3 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
7000000 USD
CY2020Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
9000000 USD
CY2019Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
9000000 USD
CY2020Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
9000000 USD
CY2019Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
9000000 USD
CY2019Q4 mo Loss Contingency Number Of Shareholders Filing Class Action Lawsuits
LossContingencyNumberOfShareholdersFilingClassActionLawsuits
2 shareholder
CY2019Q4 mo Loss Contingency Number Of Shareholders Filing Class Action Lawsuits
LossContingencyNumberOfShareholdersFilingClassActionLawsuits
2 shareholder
CY2020Q3 mo Loss Contingency Number Of Shareholders Filing Class Action Lawsuits
LossContingencyNumberOfShareholdersFilingClassActionLawsuits
2 shareholder
CY2020Q3 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
25000000 USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
39000000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
New Accounting Guidance Not Yet Adopted:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:16.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2019-12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Simplifying the Accounting for Income Taxes (Topic 740)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-01 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">’</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity.  Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.<br/></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. </span></td></tr></table></div>

Files In Submission

Name View Source Status
0000764180-20-000106-index-headers.html Edgar Link pending
0000764180-20-000106-index.html Edgar Link pending
0000764180-20-000106.txt Edgar Link pending
0000764180-20-000106-xbrl.zip Edgar Link pending
exhibit311q32020.htm Edgar Link pending
exhibit312q32020.htm Edgar Link pending
exhibit321q32020.htm Edgar Link pending
exhibit322q32020.htm Edgar Link pending
exhibit991q32020.htm Edgar Link pending
exhibit992q32020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mo-20200930.htm Edgar Link pending
mo-20200930.xsd Edgar Link pending
mo-20200930_cal.xml Edgar Link unprocessable
mo-20200930_def.xml Edgar Link unprocessable
mo-20200930_htm.xml Edgar Link completed
mo-20200930_lab.xml Edgar Link unprocessable
mo-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending